Vifor Fresenius Drug Patent Portfolio
Vifor Fresenius owns 1 orange book drug protected by 23 US patents Given below is the list of Vifor Fresenius's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10624855 | Pharmaceutical composition, comprising phosphate binder particles | 26 May, 2035 | Active |
| US11234938 | Pharmaceutical composition, comprising phosphate binder particles | 26 May, 2035 | Active |
| US11446252 | Pharmaceutical composition, comprising phosphate binder particles | 26 May, 2035 | Active |
| US10624855 | Pharmaceutical composition, comprising phosphate binder particles | 26 Nov, 2034 | Active |
| US11234938 | Pharmaceutical composition, comprising phosphate binder particles | 26 Nov, 2034 | Active |
| US11446252 | Pharmaceutical composition, comprising phosphate binder particles | 26 Nov, 2034 | Active |
| US9561251 | Pharmaceutical compositions | 23 Jul, 2030 | Active |
| US9561251 | Pharmaceutical compositions | 23 Jan, 2030 | Active |
| US10682376 | Pharmaceutical compositions | 13 May, 2029 | Active |
| US10695367 | Pharmaceutical compositions | 13 May, 2029 | Active |
| US10925896 | Pharmaceutical compositions | 13 May, 2029 | Active |
| US10925897 | Pharmaceutical compositions | 13 May, 2029 | Active |
| US10933090 | Pharmaceutical compositions | 13 May, 2029 | Active |
| US11013761 | Pharmaceutical compositions | 13 May, 2029 | Active |
| US11013762 | Pharmaceutical compositions | 13 May, 2029 | Active |
| US10682376 | Pharmaceutical compositions | 13 Nov, 2028 | Active |
| US10695367 | Pharmaceutical compositions | 13 Nov, 2028 | Active |
| US10925896 | Pharmaceutical compositions | 13 Nov, 2028 | Active |
| US10925897 | Pharmaceutical compositions | 13 Nov, 2028 | Active |
| US10933090 | Pharmaceutical compositions | 13 Nov, 2028 | Active |
| US11013761 | Pharmaceutical compositions | 13 Nov, 2028 | Active |
| US11013762 | Pharmaceutical compositions | 13 Nov, 2028 | Active |
| US6174442 | Adsorbent for phosphate from an aqueous medium, production and use of said adsorbent | 12 Jun, 2020 | Expired |
Latest Legal Activities on Vifor Fresenius's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Vifor Fresenius.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Year, Large Entity | 11 Dec, 2023 | US10682376 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 11 Dec, 2023 | US10695367 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 09 Oct, 2023 | US10624855 |
|
Recordation of Patent Grant Mailed
Critical
| 20 Sep, 2022 | US11446252 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 20 Sep, 2022 | US11446252 |
|
Email Notification
Critical
| 01 Sep, 2022 | US11446252 |
|
Issue Notification Mailed
Critical
| 31 Aug, 2022 | US11446252 |
| Dispatch to FDC | 23 Aug, 2022 | US11446252 |
|
Application Is Considered Ready for Issue
Critical
| 23 Aug, 2022 | US11446252 |
|
Issue Fee Payment Verified
Critical
| 12 Aug, 2022 | US11446252 |
|
Issue Fee Payment Received
Critical
| 12 Aug, 2022 | US11446252 |
|
Mail Notice of Allowance
Critical
| 03 Aug, 2022 | US11446252 |
|
Email Notification
Critical
| 03 Aug, 2022 | US11446252 |
|
Electronic Review
Critical
| 03 Aug, 2022 | US11446252 |
|
Notice of Allowance Data Verification Completed
Critical
| 01 Aug, 2022 | US11446252 |
Vifor Fresenius Drug Patents' Oppositions Filed in EPO
Vifor Fresenius drug patents have faced multiple oppositions in the European Patent Office. The earliest opposition was filed on Sep 28, 2017, by Stada Arzneimittel Ag. This opposition was filed on patent number EP08848615A. Click below to reveal the latest opposition data.
| Application | Filing Date | Opposition Party | Legal Status |
|---|---|---|---|
 | |||
| EP08848615A | Sep, 2017 | Interquim S.A. | Revoked |
| EP08848615A | Sep, 2017 | STADA Arzneimittel AG | Revoked |
Vifor Fresenius's Family Patents
Vifor Fresenius drugs have patent protection in a total of 34 countries. It's US patent count contributes only to 17.9% of its total global patent coverage. 3 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click
below to unlock the full patent family tree.
Vifor Fresenius Drug List
Given below is the complete list of Vifor Fresenius's drugs and the patents protecting them.
1. Velphoro
Velphoro is protected by 23 patents, out of which 1 has expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10624855
(Pediatric)
| Pharmaceutical composition, comprising phosphate binder particles |
26 May, 2035
(10 years from now)
| Active |
| US11234938
(Pediatric)
| Pharmaceutical composition, comprising phosphate binder particles |
26 May, 2035
(10 years from now)
| Active |
| US11446252
(Pediatric)
| Pharmaceutical composition, comprising phosphate binder particles |
26 May, 2035
(10 years from now)
| Active |
| US10624855 | Pharmaceutical composition, comprising phosphate binder particles |
26 Nov, 2034
(10 years from now)
| Active |
| US11234938 | Pharmaceutical composition, comprising phosphate binder particles |
26 Nov, 2034
(10 years from now)
| Active |
| US11446252 | Pharmaceutical composition, comprising phosphate binder particles |
26 Nov, 2034
(10 years from now)
| Active |
| US9561251
(Pediatric)
| Pharmaceutical compositions |
23 Jul, 2030
(5 years from now)
| Active |
| US9561251 | Pharmaceutical compositions |
23 Jan, 2030
(5 years from now)
| Active |
| US10682376
(Pediatric)
| Pharmaceutical compositions |
13 May, 2029
(4 years from now)
| Active |
| US10695367
(Pediatric)
| Pharmaceutical compositions |
13 May, 2029
(4 years from now)
| Active |
| US10925896
(Pediatric)
| Pharmaceutical compositions |
13 May, 2029
(4 years from now)
| Active |
| US10925897
(Pediatric)
| Pharmaceutical compositions |
13 May, 2029
(4 years from now)
| Active |
| US10933090
(Pediatric)
| Pharmaceutical compositions |
13 May, 2029
(4 years from now)
| Active |
| US11013761
(Pediatric)
| Pharmaceutical compositions |
13 May, 2029
(4 years from now)
| Active |
| US11013762
(Pediatric)
| Pharmaceutical compositions |
13 May, 2029
(4 years from now)
| Active |
| US10682376 | Pharmaceutical compositions |
13 Nov, 2028
(4 years from now)
| Active |
| US10695367 | Pharmaceutical compositions |
13 Nov, 2028
(4 years from now)
| Active |
| US10925896 | Pharmaceutical compositions |
13 Nov, 2028
(4 years from now)
| Active |
| US10925897 | Pharmaceutical compositions |
13 Nov, 2028
(4 years from now)
| Active |
| US10933090 | Pharmaceutical compositions |
13 Nov, 2028
(4 years from now)
| Active |
| US11013761 | Pharmaceutical compositions |
13 Nov, 2028
(4 years from now)
| Active |
| US11013762 | Pharmaceutical compositions |
13 Nov, 2028
(4 years from now)
| Active |
| US6174442 | Adsorbent for phosphate from an aqueous medium, production and use of said adsorbent |
12 Jun, 2020
(4 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Velphoro's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List